2019 Filings -
In 2019, the number of securities class action cases filed against life sciences companies reached record levels. According to Cornerstone Research, lawsuits against pharmaceutical companies increased by 40...more
4/30/2020
/ Anti-Corruption ,
Anticompetitive Behavior ,
Biotechnology ,
Class Action ,
Clinical Trials ,
Department of Justice (DOJ) ,
FDA Approval ,
Food and Drug Administration (FDA) ,
Life Sciences ,
Pharmaceutical Industry ,
Securities and Exchange Commission (SEC) ,
Securities Fraud